– USA, MA – Flexion Therapeutics, Inc. (Nasdaq: FLXN) today announced the appointment of Dr Liz Kwo, MD, Staff Vice President, Clinical Data Analytics at Anthem, to its Board of Directors.
“We are delighted to welcome Liz to our Board of Directors as her broad and deep background uniquely complements our existing skills and experiences,” said CEO, Dr. Michael Clayman, MD. “We are confident that she will provide important insights and extend our thinking as we seek to execute our strategy, drive growth and build long-term shareholder value.”
About Dr Liz Kwo
Dr. Kwo has more than 15 years of experience specializing in healthcare technology product development and commercialization, marketing and sales, strategic partnerships, and post-merger integration. As Staff Vice President of Clinical Data Analytics at Anthem, she is responsible for creating an improved automated patient and provider experience to drive down cost of care. Prior to Anthem, Dr. Kwo co-founded and served as the CEO of InfiniteMD, a telemedicine company connecting patients with physicians for second opinions. She previously worked at Medtronic, American Well and she also founded multiple venture-backed companies in educational technology, digital healthcare and healthcare supplies.
“I am honored to join Flexion’s Board of Directors, excited by the potential of ZILRETTA and the pipeline candidates and eager to help guide the company as it advances its critical mission of discovering, developing and commercializing innovative treatments for musculoskeletal conditions,” said Dr. Kwo.
Dr. Kwo earned a BA in Human Biology from Stanford University and her MD from Harvard Medical School. She holds an MBA from Harvard Business School and an MPH from Harvard TH Chan School of Public Health. She completed her residency in Preventive Care at Harvard Preventive Care and is Board Certified in Preventive Care and Occupational Medicine.
About Flexion Therapeutics
Flexion Therapeutics is a biopharmaceutical company focused on the development and commercialization of novel, local therapies for the treatment of patients with musculoskeletal conditions, beginning with osteoarthritis, a type of degenerative arthritis. The Company’s core values are focus, ingenuity, tenacity, transparency and fun.
For more information: https://flexiontherapeutics.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
